Position in DNLI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,457,345
+$521,691 QoQ
Shares Held
56,662
+16.3% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#110
of 290 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. DNLI ranks #125 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in DNLI
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,457,345 | 56,662 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $935,654 | 48,732 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $995,056 | 60,270 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $938,484 | 64,634 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $902,703 | 64,525 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,131,753 | 83,248 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,525,684 | 74,862 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,331,592 | 80,041 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $1,791,189 | 77,140 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,038,208 | 50,595 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,141,693 | 53,201 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,224,410 | 59,351 | Shares | Defined | 2023-11-13 | |
| 2021-12-31 | $367,771 | 8,246 | Shares | Defined | 2022-02-11 | |
| 2020-12-31 | $237,292 | 2,833 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||